Navigation Links
Spin-out to apply new technology for tackling infection
Date:1/24/2011

treatment to the patients who need it and cost-effective solutions for the health professionals who look after them. We have been able to stabilise bacteriophage and develop the technology for application in combating these infections."

Dr Jim Chadwick, Chief Executive of Fixed Phage, said: "The terrific potential of bacteriophage as an agent to combat infection has been known for some years but it has proved difficult to incorporate into products that are easily manufactured and offer patent protection. This superb technology, invented in Scotland, allows both these objectives to be achieved simultaneously and a prototype has been demonstrated in rigorous trial.

"FixedPhage technology can be applied to prevent infection from appearing or deal with established infection, and unlike antibiotics, has the advantage that bacteriophage constantly overcome bacterial resistance and once established, the bacterial destruction process becomes self-amplifying."

"We have shown the technology to be effective in combating infection and the model gives us options for many other applications. We anticipate significant commercial interest, particularly from the pharmaceutical industry."

Strathclyde Institute of Pharmacy and Biomedical Sciences, where the technology was discovered, is a pioneering centre for developing new medicines for illnesses and conditions including infectious diseases, cancer, heart disease and arthritis. An 8 million fundraising campaign is underway for the Institute's new 36 million building, to expand and enhance its innovative medical research, education and discovery capability to continue providing solutions to major health care problems.

In November 2010, Fixed Phage Ltd was the winner of the Life Science Innovation Award at the 2010 Nexxus Annual Life Science Awards (West), run by the networking organisation for Scotland's life scientists.

Initially, the new company will be based at, and contac
'/>"/>

Contact: Paul Gallagher
paul.gallagher@strath.ac.uk
44-014-154-82370
University of Strathclyde
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers apply systems biology and glycomics to study human inflammatory diseases
2. Experts discuss applying systematic review to the field of nutrition
3. Recipe for capturing authentic embryonic stem cells may apply to any mammal, study suggests
4. Carnegie Mellon researchers apply new statistical test
5. Researchers apply computing power to crack egg shell problem
6. BIO-key(R) to Showcase Biometric Security Applications at 2008 Biometric Technology Expo
7. Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology
8. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
9. Audience Selected as Silver Winner in This Years Wall Street Journal Technology Innovation Awards and Winner of the Semiconductors Category
10. Breakthrough optical technology to assess colon cancer risk, accuracy
11. So-called sandfish could help materials handling and process technology specialists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Researchers from North Carolina State University have developed a ... The model has applications for creating new materials as ... , "Our new technique allows us to model much ... so much more quickly," says Nan Li, lead author ... student in NC State,s Department of Materials Science and ...
(Date:8/20/2014)... Institute (HCI) at the University of Utah have identified ... BCR-ABL, the unregulated enzyme driving the blood cancer chronic ... nearly 6,000 new cases of CML will be diagnosed ... kinase inhibitors (TKIs), target BCR-ABL and are effective at ... control it in a way that allows patients to ...
(Date:8/20/2014)... fires are visible in in this image of the ... of these were most likely intentionally set in order ... a forest or stand of trees where the land ... deforestation include conversion of forestland to farms, ranches, or ... dark green of the Amazon Rainforest in the middle ...
Breaking Biology News(10 mins):Researchers develop models to study polyelectrolytes, including DNA and RNA 2Blueprint for next generation of chronic myeloid leukemia treatment 2
... Ind. - Face-to-face workplace interactions may be the best ... organ donors, according to new research from Purdue University. ... learn about health and wellness issues, but how information ... for sensitive health topics such as organ donation," said ...
... Boston University biology professor Richard Primack, graduate student ... analysis of the changing arrival dates of migratory birds ... Thoreau from the 1850,s. This research builds on earlier ... Concord respond rapidly to temperature and are now flowering ...
... Coulter, Ph.D., a neuroscientist at The Children,s Hospital ... Award for Basic Science from the American Epilepsy ... to epilepsy research on Monday, Dec. 6 at ... the most prestigious prizes for research in epilepsy, ...
Cached Biology News:Study: Personal contacts at work help people better understand organ donation 2Study: Personal contacts at work help people better understand organ donation 3Epilepsy researcher at the Children's Hospital of Philadelphia receives scientific prize 2
(Date:8/21/2014)...  China Cord Blood Corporation (NYSE: CO ... financial results for the first quarter of fiscal year ... in the US.  The Company will ... Friday, August 29, 2014 to discuss its financial performance ... developments, followed by a question and answer session.  Interested ...
(Date:8/21/2014)... Bulgaria (PRWEB) August 21, 2014 ... released today by Ontotext . Now the ... semantic analysis of structured and unstructured data is available ... the cost of enterprise technology. Organizations that do not ... for data management can use S4 since there is ...
(Date:8/21/2014)... August 21, 2014 On Wednesday of last ... to use Redox Signaling molecules, became available for purchase in ... , "The way that RENU 28 works is, if you ... down of the rate of cellular renewal within your body. ... increasing of that rate of cellular renewal. What RENU 28 ...
(Date:8/20/2014)... American Indians largely were wiped out by diseases such ... to the New World by European explorers., One report ... in the Americas shortly before Europeans arrived, and roughly ... But new research led by anthropological geneticists Anne Stone ... University of Tubingen in Germany indicates the diagnosis of ...
Breaking Biology Technology:China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4RENU 28 Skin Care Now Available in Australia and New Zealand 2Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3
... Hospitals in Western Pennsylvania Earn Designation, PITTSBURGH, ... named Allegheny General Hospital, UPMC Presbyterian Shadyside and ... Rare Cancers., Complex and rare cancers comprise ... making it difficult for patients to locate or,research ...
... has announced,development of a chemically synthesized vaccine specific ... patented Replikins(TM) technology.,When the vaccine was administered orally ... Taura virus. The specificity of the protective,effect was ... active,regions in the vaccine, and as a result ...
... Prescribing of Copaxone over an Interferon-Beta Therapy, According to a ... ... Resources, WALTHAM, Mass., March 11 Decision Resources, one ... issues, finds that Teva Pharmaceutical,s Copaxone has the,greatest patient share among ...
Cached Biology Technology:Highmark Blue Cross Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 2Highmark Blue Cross Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 3Replikins Oral Vaccine Synthesized in 7 Days Protects 91% of Shrimp Against a Lethal Virus 2Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 2Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 3
HOXC11 Antibody...
Anti-NeuroD 6 Immunogen: Synthetic peptide. Available Date: 36708...
HOXC11 Antibody...
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Biology Products: